-
Uncategorized1 week agoDDW Highlights: 31 March 2026
The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates the key stories of the previous week to keep...
-
Uncategorized1 week ago
Biogen to buy Apellis for $5.6B
Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday. The deal will allow Biogen to get hold of the kidney...
-
Uncategorized1 week ago
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drug
Eli Lilly to buy Centessa for $6.3B to get sleep disorder drug
-
Uncategorized1 week agoBiotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what’s been observed over a...
-
Uncategorized1 week agoSTAT+: HSA companies struck it big in Trump’s tax bill. They’re lobbying for more
WASHINGTON — Sellers of health savings accounts see an opening for expanding their market, and they’re ramping up lobbying efforts to seize the opportunity. A group...
-
Uncategorized1 week agoCommon Ancestry Limits Protein Sequence Exploration, Computational Study Shows
For all the excitement surrounding AlphaFold and the surge of AI‑driven protein design tools, one fact often goes unexamined: nearly every model is trained on databases...
-
Uncategorized1 week ago
Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics
Nature Biotechnology, Published online: 31 March 2026; doi:10.1038/s41587-026-03068-6 Simultaneous profiling of adenylated and non-adenylated RNAs reveals regulatory programs across diverse cell types.
-
Uncategorized1 week agoSTAT+: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting
Takeda Pharmaceuticals will lay off nearly 250 workers in Cambridge, the state’s largest biopharma employer announced through a state filing. The layoffs will begin in July, although some...
-
Uncategorized1 week agoBlackstone closes $6.3B fund for life sciences investing
It's the biggest life sciences private fund ever raised, coming in nearly 40% larger than its Blackstone predecessor vehicle. Read More
-
Uncategorized1 week agoSTAT+: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to organization
In the latest dustup over a groundbreaking HIV prevention medicine, Doctors Without Borders has harshly criticized the manufacturer for refusing to sell its treatment directly to...
Sanofi Bispecific Scores in Asthma, Rhinosinusitis, but Eczema Bet Doesn’t Pay Off
